Skinvisible Announces New Board of Directors Member
Greg McCartney, President of AMEX Listed Genesis Bioventures, Brings Biotech &
Healthcare Industry Experience to Board of Directors
LAS VEGAS, Jan. 14 /PRNewswire-FirstCall/ -- Skinvisible, Inc. (OTC:SKVI)
(BULLETIN BOARD: SKVI) (Website: http://www.skinvisible.com/) is pleased to
announce the election of Mr. Greg McCartney to the Board of Directors at the
Annual General Meeting held on January 10, 2005. McCartney is presently
President, CEO and Chairman of American Stock Exchange listed Genesis
Bioventures (AMEX:GBI). Mr. McCartney has over 20 years experience serving as
officer and director of both private and public companies in various
manufacturing and technology industries. Prior to founding Genesis Bioventures
in 1997, Mr. McCartney was owner and director of a private consulting firm
specializing in financing and venture capital. "Mr. McCartney's experience in
the Biotech & Healthcare industry in the area of licensing will be a major
asset as we continue forward in licensing our Invisicare(R) delivery
technology," said Terry Howlett.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030416/LAW068LOGO) Headquartered in Las Vegas, Nevada, Skinvisible, Inc. is focused on the
development of innovative topical polymer-based delivery systems and related
technologies incorporating its patented formula/process for combining
hydrophilic and hydrophobic polymers into stable water emulsions. Skinvisible's
primary marketing and sales objectives are to license its technologies and/or
sell its delivery systems to provide enhanced product performance for
established brand manufacturers and providers of prescription,
over-the-counter, cosmetic, and skincare products. In addition Skinvisible
formulates and manufactures products for private label customers.
For Corporate Information Contact: T. Howlett -- Skinvisible, Inc. --
Ph. (702) 433-7154 / Fax (702) 433-7192 / Email: Media Contact: Tommi Hanley -- Thompson Lloyd Communications --
Ph. (250) 860-9959 / Email: This press release contains "forward looking" statements within the meaning of
Section 21A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934 as amended, and are subject to the safe harbors
created thereby. Such statements involve certain risks and uncertainties
associated with an emerging company. Actual results could differ materially
from those projected in the forward looking statements as a result of risk
factors discussed in Skinvisible, Inc. reports that will be on file with the US
Securities and Exchange Commission (including but not limited to the report on
Form 10-QSB for the quarter ending September 30, 2004). http://www.newscom.com/cgi-bin/prnh/20030416/LAW068LOGO http://photoarchive.ap.org/ DATASOURCE: Skinvisible, Inc.
CONTACT: T. Howlett of Skinvisible, Inc., +1-702-433-7154, or fax, +1-702-433-7192, ; or Tommi Hanley of Thompson Lloyd Communications, +1-250-860-9959, , for Skinvisible, Inc.
Web site: http://www.skinvisible.com/
|